Edwards Sapien 3 Transcatheter Heart Valve
Sponsors
Edwards Lifesciences, Insel Gruppe AG, University Hospital Bern, National Heart, Lung, and Blood Institute (NHLBI)
Conditions
Aortic Valve DiseaseAortic Valve StenosisMitral Valve Failure
Unknown Phase
Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve/ The SAPIEN 3 Study
CompletedNCT01808287
Start: 2013-01-31End: 2019-12-17Updated: 2020-04-01
Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis.
CompletedNCT03011346
Start: 2017-02-08End: 2022-02-16Updated: 2022-03-10
NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation
CompletedNCT03015194
Start: 2017-06-20End: 2023-04-13Updated: 2023-08-15